The current valuation score of Zentek Ltd is 8.82, ranking 85 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -7.42, which is -50.35% below the recent high of -3.68 and -152.33% above the recent low of -18.72.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.